The Food and Drug Administration on Thursday issued an emergency use authorization for what it said is the first device that can detect COVID-19 in breath samples.
The InspectIR COVID-19 Breathalyzer is about the size of a piece of carry-on luggage, the FDA said, and can be used in doctor’s offices, hospitals and mobile testing sites. The test, which can provide results in less than three minutes, must be carried out under the supervision of a licensed health care provider.
Dr. Jeff Shuren, director of the FDA’s Center for Devices and Radiological Health, called the device “yet another example of the rapid innovation occurring with diagnostic tests for COVID-19.”
The FDA said the device was 91.2% accurate at identifying positive test samples and 99.3% accurate at identifying negative test samples.
“InspectIR expects to be able to produce approximately 100 instruments per week, which can each be used to evaluate approximately 160 samples per day,” the agency said. “At this level of production, testing capacity using the InspectIR COVID-19 Breathalyzer is expected to increase by approximately 64,000 samples per month.”
A SpaceX-NASA mission that was due to launch into orbit Friday was called off and delayed until Saturday.
Diabetes and weight-loss drug Wegovy is shown to help people with a heart condition, according to a new study.
Cheddar News checks in with a coast-to-coast forecast of the weather for Friday, Aug. 25, 2023.
A Jersey Shore man has painted sea shells -- nearly 500 of them -- to raise awareness around epilepsy that have traveled as far as Asia and Australia.
The International Fund for Animal Welfare, which protects animals worldwide, is opening a first-of-its-kind short-term dolphin hospital on Cape Cod this month that it hopes will not only improve survivability rates, but also enhance the research it has developed over 25 years.
A new humanoid robot designed to do dull and dirty jobs has been unveiled by NASA.
The Mercury retrograde lasts until Sept. 15 as astrologers blame planets and stars for communications issues.
A new study suggests that teaching kids creativity can increase resilience.
A new study shows that marketers may be overstating fish oil benefits.
The Food and Drug Administration issued a warning about two brands of eye drops being sold online that they both have potential fungal and bacterial contamination.
